Hongbo Liu Selected Research

Anthracosis

8/2018	Time trends and future prediction of coal worker's pneumoconiosis in opencast coal mine in China based on the APC model.
2/2018	Estimated economic costs of coal workers' pneumoconiosis among coal workers redeployed from the Fuxin mining group in China.
1/2018	Establishment and application of an index system for prevention of coal workers' pneumoconiosis: a Delphi and analytic hierarchy process study in four state-owned coal enterprises of China.
1/2016	Estimates and Predictions of Coal Workers' Pneumoconiosis Cases among Redeployed Coal Workers of the Fuxin Mining Industry Group in China: A Historical Cohort Study.
1/2015	Cost-Effectiveness of Coal Workers' Pneumoconiosis Prevention Based on Its Predicted Incidence within the Datong Coal Mine Group in China.
8/2009	Prevalence characteristics and prediction of coal workers' pneumoconiosis in the Tiefa Colliery in China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hongbo Liu Research Topics

Disease

17	Inflammation (Inflammations) 09/2022 - 05/2013
17	Infections 03/2022 - 02/2004
16	Neoplasms (Cancer) 08/2022 - 01/2010
9	Fibrosis (Cirrhosis) 01/2022 - 03/2005
7	Disease Resistance 01/2020 - 05/2008
6	Breast Neoplasms (Breast Cancer) 08/2022 - 01/2015
6	Anthracosis 08/2018 - 08/2009
5	Kidney Diseases (Kidney Disease) 11/2021 - 01/2021
5	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 08/2009
4	Cognitive Dysfunction 01/2022 - 03/2015
4	Diarrhea 11/2020 - 06/2007
4	Insulin Resistance 02/2018 - 10/2015
3	COVID-19 03/2022 - 11/2020
3	Type 2 Diabetes Mellitus (MODY) 10/2018 - 01/2018
2	Asthma (Bronchial Asthma) 09/2022 - 01/2019
2	Foot and Mouth Disease Hand (Hand, Foot, Mouth Disease) 01/2022 - 01/2021
2	Gout 12/2021 - 11/2014
2	Chronic Renal Insufficiency 12/2021 - 11/2020
2	Glioma (Gliomas) 11/2021 - 10/2019
2	Multiple Sclerosis 01/2021 - 01/2019
2	Relapsing-Remitting Multiple Sclerosis 01/2021 - 01/2019
2	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 01/2018
2	Wounds and Injuries (Trauma) 01/2021 - 01/2020
2	Guillain-Barre Syndrome 12/2020 - 12/2018
2	Albuminuria 11/2020 - 01/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020 - 01/2020
2	Carcinogenesis 12/2019 - 01/2012
2	Hepatitis B 01/2018 - 11/2011
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2018 - 10/2017
2	Brain Injuries (Brain Injury) 01/2017 - 04/2015
2	Obesity 11/2016 - 10/2016
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2014 - 10/2013
2	Chronic Hepatitis B 05/2013 - 08/2009
1	Respiratory Hypersensitivity 09/2022
1	Ischemic Stroke 05/2022

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 09/2022 - 08/2009
10	CytokinesIBA 09/2022 - 04/2010
8	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2012
7	Coal (Coals)IBA 08/2018 - 08/2009
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2015
5	Messenger RNA (mRNA)IBA 09/2022 - 11/2011
5	VaccinesIBA 03/2022 - 01/2021
5	MicroRNAs (MicroRNA)IBA 10/2020 - 01/2014
4	HMGB1 Protein (HMG1)IBA 01/2021 - 04/2010
4	EnzymesIBA 01/2018 - 03/2005
4	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 06/2007
4	Triglycerides (Triacylglycerol)IBA 01/2018 - 10/2015
3	AlbuminsIBA 12/2021 - 01/2013
3	AntibodiesIBA 11/2021 - 01/2019
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2021 - 11/2016
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021 - 06/2015
3	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2016
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2020
3	Biological ProductsIBA 10/2020 - 12/2019
3	ChemokinesIBA 03/2020 - 01/2019
3	jasmonic acid (jasmonate)IBA 04/2019 - 05/2008
3	Phosphotransferases (Kinase)IBA 02/2018 - 11/2016
3	LipidsIBA 01/2018 - 10/2015
3	Interleukin-6 (Interleukin 6)IBA 01/2017 - 10/2015
2	CreatinineIBA 12/2021 - 03/2016
2	NucleotidesIBA 11/2021 - 01/2021
2	Long Noncoding RNAIBA 07/2021 - 12/2019
2	Azithromycin (Zithromax)FDA LinkGeneric 11/2020 - 01/2017
2	SaltsIBA 02/2020 - 05/2008
2	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2020 - 01/2017
2	Terpenes (Terpenoids)IBA 01/2020 - 05/2008
2	Glutathione (Reduced Glutathione)IBA 01/2020 - 05/2008
2	FlavonoidsIBA 01/2020 - 05/2008
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 05/2016
2	Histones (Histone)IBA 10/2019 - 01/2010
2	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 04/2019 - 01/2009
2	Insulin (Novolin)FDA Link 02/2018 - 11/2016
2	Blood Glucose (Blood Sugar)IBA 02/2018 - 01/2018
2	Diethylhexyl Phthalate (DEHP)IBA 02/2018 - 11/2016
2	LeptinIBA 02/2018 - 11/2016
2	Hepatitis B e AntigensIBA 01/2018 - 05/2013
2	Angiopoietin-Like Protein 8IBA 01/2018 - 01/2018
2	Small Interfering RNA (siRNA)IBA 01/2018 - 01/2012
2	AntigensIBA 01/2018 - 01/2016
2	3-nitrotyrosineIBA 01/2017 - 03/2016
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2017 - 10/2015
2	C-Reactive ProteinIBA 03/2016 - 10/2015
2	PhytoalexinsIBA 11/2014 - 05/2008
2	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2014 - 10/2013
2	Chitin SynthaseIBA 11/2007 - 02/2004
1	Expectorants (Mucolytics)IBA 09/2022
1	Mucin 5ACIBA 09/2022
1	Aquaporin 5IBA 09/2022
1	OvalbuminIBA 09/2022
1	Protons (Proton)IBA 08/2022
1	Eptifibatide (Integrilin)FDA Link 05/2022
1	Tirofiban (Aggrastat)FDA Link 05/2022
1	2019-nCoV Vaccine mRNA-1273IBA 03/2022
1	BNT162 VaccineIBA 03/2022
1	COVID-19 VaccinesIBA 03/2022

Therapy/Procedure

11	Therapeutics 01/2021 - 01/2012
2	Aftercare (After-Treatment) 08/2022 - 01/2018
2	Immunotherapy 01/2021 - 01/2018
1	Neoadjuvant Therapy 08/2022